1. Home
  2. SNGX vs BLMZ Comparison

SNGX vs BLMZ Comparison

Compare SNGX & BLMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNGX
  • BLMZ
  • Stock Information
  • Founded
  • SNGX 1987
  • BLMZ 2017
  • Country
  • SNGX United States
  • BLMZ Japan
  • Employees
  • SNGX N/A
  • BLMZ N/A
  • Industry
  • SNGX Biotechnology: Pharmaceutical Preparations
  • BLMZ
  • Sector
  • SNGX Health Care
  • BLMZ
  • Exchange
  • SNGX Nasdaq
  • BLMZ NYSE
  • Market Cap
  • SNGX 6.5M
  • BLMZ 5.3M
  • IPO Year
  • SNGX 1987
  • BLMZ 2024
  • Fundamental
  • Price
  • SNGX $2.17
  • BLMZ $0.16
  • Analyst Decision
  • SNGX
  • BLMZ
  • Analyst Count
  • SNGX 0
  • BLMZ 0
  • Target Price
  • SNGX N/A
  • BLMZ N/A
  • AVG Volume (30 Days)
  • SNGX 198.8K
  • BLMZ 2.3M
  • Earning Date
  • SNGX 05-09-2025
  • BLMZ 02-15-2025
  • Dividend Yield
  • SNGX N/A
  • BLMZ N/A
  • EPS Growth
  • SNGX N/A
  • BLMZ N/A
  • EPS
  • SNGX N/A
  • BLMZ N/A
  • Revenue
  • SNGX $119,371.00
  • BLMZ $1,535,822.00
  • Revenue This Year
  • SNGX N/A
  • BLMZ N/A
  • Revenue Next Year
  • SNGX N/A
  • BLMZ N/A
  • P/E Ratio
  • SNGX N/A
  • BLMZ N/A
  • Revenue Growth
  • SNGX N/A
  • BLMZ 71.48
  • 52 Week Low
  • SNGX $1.68
  • BLMZ $0.11
  • 52 Week High
  • SNGX $14.83
  • BLMZ $4.30
  • Technical
  • Relative Strength Index (RSI)
  • SNGX 52.69
  • BLMZ N/A
  • Support Level
  • SNGX $1.97
  • BLMZ N/A
  • Resistance Level
  • SNGX $2.21
  • BLMZ N/A
  • Average True Range (ATR)
  • SNGX 0.15
  • BLMZ 0.00
  • MACD
  • SNGX 0.03
  • BLMZ 0.00
  • Stochastic Oscillator
  • SNGX 86.96
  • BLMZ 0.00

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

About BLMZ BLOOMZ INC

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

Share on Social Networks: